Erlozest 150mg Tablet: Effective Solution for Your Needs

Erlozest 150mg Tablet

Uses:

• Advanced or metastatic non-small lung cancer (NSCLC).
• Advanced or metastatic pancreatic cancer.

How it works:

• Erlozest 150 mg prevents the activity of a protein called epidermal growth factor receptor (EGFR), a protein involved in the spread and growth of cancer cells.

Important information:

• Always take this medicine as prescribed by the doctor.
• The tablet must be taken at least one hour before or two hours after taking food.
• Do not take this medication with food.
• Do not take this medication if you are under 18 years of age.
• Keep out of sight and reach of children.
• Store at controlled room temperature between 15°C to 30°C. Do not freeze.

Safety advice:

• Pregnancy: do not take this medicine during pregnancy unless your doctor recommends it.
• Breastfeeding: do not take Erlozest 150 mg if you are breastfeeding.
• Lungs: it is unknown whether Erlozest 150 mg Tablets affect the lungs. Please consult your doctor.
• Liver: this medicine is not recommended in patients with severe liver diseases.
• Alcohol: it is unknown whether it is safe to consume alcohol with Erlozest 150 mg Tablets. Please consult your doctor.
• Driving: it is not known whether Erlozest 150 mg Tablet alters the ability to drive. Do not drive if you experience symptoms affecting your ability to concentrate and react.

Side effects:

• Serious: persistent or severe diarrhea, pain in the eye, blurred vision, sudden difficulty in breathing accompanied by cough and fever, severe pain in your abdomen, liver failure.
• Common: rash, worsened in sun-exposed areas, loss of appetite, decreased weight, infection, headache, depression, nausea, mouth irritation, indigestion, hair loss, dry skin, itching, acne, cracked skin, tiredness, inflammation around fingernail, bleeding from nose, stomach, intestines, reduced kidney function.

FAQ:

• Q 1. How should I take Erlozest 150 mg? Always take this medicine as prescribed by the doctor. The tablet must be taken at least one hour before or two hours after taking food, and it should be taken at a fixed time daily.
• Q 2. Does Erlozest 150 mg cause eye dryness? Yes, this medication can cause eye dryness and conjunctivitis, and hence patients are advised to inform the history of vision problems, and use of contact lenses before taking this medication.
• Q 3. Can I take Erlozest 150 mg during pregnancy? This medication is highly unsafe in pregnancy as it can cause harmful effects in the developing baby. Avoid making plans to have children or during pregnancy while taking this medication.
• Q 4. Can I smoke while taking Erlozest 150 mg? Avoid smoking while taking this medication, as it can decrease the effectiveness of this medication.
• Q 5. How long can I take Erlozest 150 mg? Erlozest 150 mg is taken daily as long as prescribed by the doctor and duration of time varies from patient to patient depending upon the severity of the disease.
• Q 6. Can Erlozest 150 mg be used in kidney disorders? This medication is not recommended in kidney patients as it can worsen the condition of the disease.

Fact box:

• Molecule name: Erlotinib.
• Therapeutic class: Tyrosine kinase inhibitor.
• Pharmacological class: Anti-Neoplastics.
• Indications:
  • Advanced or metastatic non-small lung cancer (NSCLC).
  • Advanced or metastatic pancreatic cancer.

Tags: erlozest, 150mg, tablet, medicine, health, pharmacy